{"id":"https://openalex.org/W2589972844","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","title":"Long-term efficacy and pharmacodynamic parameter analysis in pretreated KRAS-mutant metastatic colorectal carcinoma (mCRC) patients treated with RG7160 (GA201), an antibody-dependent cellular cytotoxicity (ADCC)-enhanced monoclonal anti-EGFR antibody.","display_name":"Long-term efficacy and pharmacodynamic parameter analysis in pretreated KRAS-mutant metastatic colorectal carcinoma (mCRC) patients treated with RG7160 (GA201), an antibody-dependent cellular cytotoxicity (ADCC)-enhanced monoclonal anti-EGFR antibody.","publication_year":2013,"publication_date":"2013-02-01","ids":{"openalex":"https://openalex.org/W2589972844","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","mag":"2589972844"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2013.31.4_suppl.379","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028020706","display_name":"Jean\u2010Pierre Delord","orcid":"https://orcid.org/0000-0001-7305-5561","observed_orcids":["https://orcid.org/0000-0001-7305-5561"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Delord","raw_affiliation_strings":["Institut Claudius Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015190461","display_name":"Josep M. Tabernero","orcid":"https://orcid.org/0000-0002-2495-8139","observed_orcids":["https://orcid.org/0000-0002-2495-8139"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Josep Tabernero","raw_affiliation_strings":["Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048223620","display_name":"Rocio Garc\u00eda\u2010Carbonero","orcid":"https://orcid.org/0000-0002-3342-397X","observed_orcids":["https://orcid.org/0000-0002-3342-397X"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rocio Garcia-Carbonero","raw_affiliation_strings":["Hospital Universitario Virgen del Rocio, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Rocio, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091727687","display_name":"Andr\u00e8s M.R. Cervantes","orcid":"https://orcid.org/0000-0003-3806-3691","observed_orcids":["https://orcid.org/0000-0003-3806-3691","https://orcid.org/0000-0003-4644-3977"]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Andres Cervantes-Ruiperez","raw_affiliation_strings":["Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I4210158373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002046745","display_name":"Carlos Gomez\u2010Roca","orcid":"https://orcid.org/0000-0002-8043-2529","observed_orcids":["https://orcid.org/0000-0002-8043-2529"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carlos Alberto Gomez-Roca","raw_affiliation_strings":["Institut Claudius Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033615082","display_name":"Yann Berg\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yann Berge","raw_affiliation_strings":["Institut Claudius Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110804897","display_name":"Jaume Capdevila","orcid":"https://orcid.org/0000-0003-0718-8619","observed_orcids":["https://orcid.org/0000-0003-0718-8619","https://orcid.org/0000-0001-8017-9941"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jaume Capdevila","raw_affiliation_strings":["Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107984737","display_name":"Jesus Corral Jaime","orcid":"https://orcid.org/0000-0003-4377-2871","observed_orcids":["https://orcid.org/0000-0003-4377-2871"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jesus Corral Jaime","raw_affiliation_strings":["Hospital Universitario Virgen del Rocio, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen del Rocio, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100993574","display_name":"Desamparados Roda Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I16097986","display_name":"Universitat de Val\u00e8ncia","ror":"https://ror.org/043nxc105","country_code":"ES","type":"education","lineage":["https://openalex.org/I16097986"]},{"id":"https://openalex.org/I4210158373","display_name":"INCLIVA Health Research Institute","ror":"https://ror.org/059wbyv33","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158373"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Desamparados Roda Perez","raw_affiliation_strings":["Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, INCLIVA, University of Valencia, Valencia, Spain","institution_ids":["https://openalex.org/I16097986","https://openalex.org/I4210158373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110985671","display_name":"Sophie Golding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sophie Golding","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111867493","display_name":"David E. Oppenheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Oppenheim","raw_affiliation_strings":["King's College London School of Medicine, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King's College London School of Medicine, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043807824","display_name":"Sophia Soehrman Brossard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Sophia Soehrman Brossard","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000327811","display_name":"Christoph Mancao","orcid":"https://orcid.org/0009-0009-1531-3644","observed_orcids":["https://orcid.org/0009-0009-1531-3644"]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christoph Mancao","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057770837","display_name":"Farzin Farzaneh","orcid":"https://orcid.org/0000-0002-9275-2415","observed_orcids":["https://orcid.org/0000-0002-9275-2415"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Farzin Farzaneh","raw_affiliation_strings":["Department of Haematological Medicine, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematological Medicine, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034087043","display_name":"Alexandre Passioukov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Alexandre Passioukov","raw_affiliation_strings":["Roche Glycart AG, Schlieren, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche Glycart AG, Schlieren, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110243","display_name":"Luigi Manenti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119458","display_name":"Roche (China)","ror":"https://ror.org/02hv5e369","country_code":"CN","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210119458"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Luigi Manenti","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210119458"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Marion Gabriele Ott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Marion Gabriele Ott","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd., Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd., Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021624793","display_name":"Jean\u2010Charles Soria","orcid":"https://orcid.org/0000-0001-9597-0701","observed_orcids":["https://orcid.org/0000-0001-9597-0701"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Charles Soria","raw_affiliation_strings":["Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"31","issue":"4_suppl","first_page":"379","last_page":"379"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-egfr-monoclonal-antibody","display_name":"anti-EGFR monoclonal antibody","score":0.9190000295639038},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tumor-immune-cell-infiltration","display_name":"tumor immune cell infiltration","score":0.7059999704360962},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7910000085830688},{"id":"https://openalex.org/keywords/tumor-infiltrating-macrophages","display_name":"tumor-infiltrating macrophages","score":0.7799999713897705},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5260000228881836},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.7229999899864197},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.38499999046325684},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9080504179000854},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7439904808998108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6398292183876038},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.6251236796379089},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5854735970497131},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5621654391288757},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5434714555740356},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.523232638835907},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5217419862747192},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.5147311687469482},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5051310658454895},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.47866687178611755},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.43786880373954773},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4235777258872986},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34853601455688477},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.32600629329681396},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3162228763103485},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2805261015892029},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26640090346336365},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23612555861473083},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.1689586043357849},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2013.31.4_suppl.379","doi":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2013.31.4_suppl.379","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034024147","https://openalex.org/W2092741156","https://openalex.org/W2050400262","https://openalex.org/W2602472325","https://openalex.org/W2598884720","https://openalex.org/W2314994356","https://openalex.org/W2331754067","https://openalex.org/W2096617104","https://openalex.org/W2171528830","https://openalex.org/W3081149577"],"abstract_inverted_index":{"379":[0],"Background:":[1],"EGFR-positive,":[2],"KRAS-mutant":[3,60,295],"mCRC":[4,61],"patients":[5,146,162,293],"(pts)":[6],"do":[7],"not":[8],"benefit":[9],"from":[10,102],"anti-EGFR":[11,28],"treatment.":[12],"In":[13,54,240],"this":[14,312],"pt":[15,169],"population":[16],"we":[17,92],"investigated":[18],"the":[19,193,301],"efficacy":[20],"of":[21,38,43,117,145,155,206,226,233,303],"single-agent":[22],"GA201,":[23],"a":[24,115],"novel":[25],"dual":[26],"acting,":[27],"antibody":[29],"which":[30,150],"was":[31,86,131,141,151,243,252],"glycoengineered":[32],"to":[33,87,125,200],"enhance":[34],"ADCC":[35],"on":[36,73],"top":[37],"signaling":[39],"blockage.":[40],"This":[41],"stimulation":[42],"immune":[44,230,269,309],"effector":[45],"cells":[46],"may":[47],"improve":[48],"long":[49,307],"term":[50,308],"clinical":[51],"outcomes.":[52],"Methods:":[53],"an":[55,305],"open-label,":[56],"multicenter,":[57],"non-randomized":[58],"study,":[59],"pts":[62,113,156,215],"(1-2":[63],"prior":[64],"chemotherapy":[65],"lines)":[66],"were":[67,177],"treated":[68],"with":[69,180,277,289,294],"GA201":[70,119,290],"(1400":[71],"mg":[72,81],"day":[74],"1":[75,168],"and":[76,99,105,108,167,187,208,281],"8":[77,148],"then":[78],"by":[79],"1400":[80],"q2W).":[82],"The":[83,297],"primary":[84],"endpoint":[85],"investigate":[88],"tumor":[89,210,250,268],"response.":[90],"Here":[91],"report":[93],"response":[94,140,310],"rates,":[95],"overall":[96,129,139],"survival":[97,130],"(OS)":[98],"pharmacodynamics":[100,298],"analyses":[101,299],"archival,":[103],"pre-":[104,207],"on-treatment":[106],"biopsies":[107,211,251],"blood":[109],"samples.":[110],"Results:":[111],"25":[112],"received":[114],"median":[116],"5":[118],"infusions":[120],"(range":[121,134],"2\u201324),":[122],"for":[123,213],"up":[124],"414":[126],"days.":[127],"Median":[128],"9.3":[132],"months":[133],"1.2":[135],"\u2013":[136],"21.2).":[137],"Best":[138],"stable":[142],"disease":[143],"(40%":[144],"at":[147,157,164,171,238,272],"weeks),":[149],"maintained":[152],"in":[153,160,248,256,292,311],"24%":[154],"16":[158],"weeks,":[159],"2":[161],"(8%)":[163],"24":[165],"weeks":[166],"(4%)":[170],"42":[172],"weeks.":[173],"Treatment-related":[174],"adverse":[175,196],"events":[176],"all":[178],"manageable":[179],"rash":[181],"(20%":[182,185],"grade3),":[183],"hypomagnesaemia":[184],"g3/4)":[186],"infusion-related":[188],"reactions":[189],"(4%":[190],"g3)":[191],"being":[192],"most":[194],"common":[195],"events;":[197],"none":[198],"led":[199],"discontinuation":[201],"or":[202],"dose":[203],"reduction.":[204],"Comparison":[205],"post-treatment":[209],"evaluable":[212],"11":[214],"revealed":[216],"that":[217,245],"tumor-infiltrating":[218],"cell":[219,270],"counts":[220],"increased":[221],"notably":[222,253],"after":[223],"one":[224],"cycle":[225],"therapy":[227],"(median":[228,259],"composite":[229],"reactive":[231],"score":[232],"1491":[234],"vs":[235,263],"898":[236],"cells/mm3":[237],"baseline).":[239],"addition,":[241],"it":[242],"noted":[244],"EGFR":[246],"H-score":[247],"baseline":[249,273],"higher":[254],"than":[255],"archival":[257],"tumors":[258],"[range]":[260],"52":[261],"[13\u2013161]":[262],"3":[264],"[1\u201381],":[265],"respectively).":[266],"High":[267],"infiltration":[271],"might":[274],"be":[275],"associated":[276],"better":[278],"treatment":[279],"outcome":[280],"long-term":[282],"survival.":[283],"Conclusions:":[284],"Encouraging":[285],"OS":[286],"is":[287],"achieved":[288],"monotherapy":[291],"tumors.":[296],"support":[300],"hypothesis":[302],"triggering":[304],"enhanced":[306],"pretreated":[313],"patient":[314],"population.":[315],"Clinical":[316],"trial":[317],"information:":[318],"NCT00721266.":[319]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2017-03-03T00:00:00"}